Answer
As a precaution, it is preferable to avoid desloratadine (Neoclarityn) during pregnancy, although data from more than 1,000 pregnancy outcomes indicate no malformative or foetal/neonatal toxicity.
Sources for this answer
- Neoclarityn 5 mg film-coated tabletsOrganon Pharma (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 23Document updated
Sources checked